VTAMA: payments to doctors
Payments that named VTAMA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $16.8M
- Providers
- 16,503
- Transactions
- 164,842
- Average per transaction
- $102
The per-transaction average — $102 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 16,503 providers the average total is $1,017, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Dermavant Sciences, Inc. | $12,452,728 | 74.2% |
| Organon | $4,322,609 | 25.8% |